目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.4 STUDY SCOPE
1.4.1 SEGMENTS CONSIDERED
1.4.2 YEARS CONSIDERED
1.4.3 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Objectives of secondary research
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries (supply- and demand-side participants)
2.1.2.2 Key objective of primary research
2.2 MARKET ESTIMATION
2.2.1 GLOBAL MARKET ESTIMATION
2.2.1.1 Company revenue analysis (bottom-up approach)
2.2.1.1.1 Revenue share analysis of BD& Co.
2.2.1.2 MnM repository analysis
2.2.1.3 Primary interviews
2.2.2 INSIGHTS OF PRIMARY EXPERTS
2.2.3 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY
3.1 STRATEGIC IMPERATIVES FOR KEY STAKEHOLDERS
3.1.1 FILL FINISH CONSUMABLE MANUFACTURERS
3.1.1.1 Shift to RTU & COP containers
3.1.1.2 Annex-1 compliance support for customers
3.1.1.3 PFAS-free, PPWR-ready portfolio to become table-stakes for customers
3.1.2 FILL FINISH EQUIPMENT MANUFACTURERS
3.1.2.1 Shift to robotic processes with nested RTU vials, PFS, and cartridges
3.1.2.2 Integration of predictive maintenance
3.1.3 FILL FINISH CDMOS
3.1.3.1 Biologics play vs. growth in niche segments of CGT, ADC, and radiopharma
3.1.3.2 Integration of predictive maintenance

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN FILL FINISH MANUFACTURING MARKET
4.2 EUROPE: FILL FINISH MANUFACTURING MARKET, BY PRODUCT AND COUNTRY (2025)
4.3 FILL FINISH MANUFACTURING MARKET, BY PRODUCT
4.4 FILL FINISH MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 GLP-1, biosimilars, and vaccines pipeline expansion driving volumes for biologics fill-finish
5.2.1.2 Annex-1 compliance requirements driving equipment upgradation
5.2.1.3 Increasing demand for automated & small-batch solutions to cater to personalized medicine manufacturing
5.2.1.4 Outsourcing to fill-finish CDMOs driving capacity expansions
5.2.2 RESTRAINTS
5.2.2.1 High CAPEX requirements for isolators & robotic aseptic lines to deter adoption
5.2.2.2 Skilled labor shortage in sterile operations due to high CDMO staffing
5.2.3 OPPORTUNITIES
5.2.3.1 Demand for cell & gene therapy/mRNA small-batch manufacturing
5.2.3.2 Onshoring/Nearshoring for North America and Europe
5.2.3.3 Integration of predictive analytics
5.2.4 CHALLENGES
5.2.4.1 Need for sustainable & PFAS-free consumables for fill finish
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Aseptic processing
5.3.1.2 Sterilization
5.3.2 COMPLIMENTARY TECHNOLOGIES
5.3.2.1 Automation and robotics
5.3.2.2 Isolator technology
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Single use systems
5.3.3.2 Inspection and quality control
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4.1 KEY LAUNCHES AND PIPELINE OF BIOSIMILARS, GLP-1, CGT, ADC & RADIOPHARMACEUTICALS
5.4.2 US FDA APPROVAL TREND OF DRUG APPROVALS BY DOSAGE FORM
5.4.2.1 Injectable vs. other dosage forms
5.4.2.2 Subcutaneous vs. intramuscular biologics
5.5 FILL FINISH OUTSOURCING TRENDS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND, BY REGION
5.6.2 INDICATIVE PRICING ANALYSIS, BY PRODUCT
5.7 VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
5.9.1 CONSUMABLES
5.9.2 INSTRUMENTS
5.9.3 END USERS
5.9.4 MANUFACTURING SITES, EXPANSIONS, AND CAPEX TRENDS OF KEY FILL FINISH CDMOS, 2022-2025
5.10 PATENT ANALYSIS
5.10.1 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
5.10.2 LIST OF KEY PATENTS, 2023-2024
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY FRAMEWORK
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.1.2 Canada
5.11.2.2 Europe
5.11.2.2.1 Germany
5.11.2.2.2 France
5.11.2.2.3 UK
5.11.2.3 Asia Pacific
5.11.2.3.1 China
5.11.2.3.2 Japan
5.11.2.3.3 India
5.11.2.4 Rest of the World
5.11.2.4.1 Brazil
5.11.2.4.2 Argentina
5.11.2.4.3 Saudi Arabia
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 PORTER'S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTES
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 INTENSITY OF COMPETITIVE RIVALRY
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 KEY BUYING CRITERIA
5.14.2.1 Key unmet needs of end users
5.14.2.1.1 Truly flexible, multi-format lines
5.14.2.1.2 Low-MOQ custom packs for clinical CGT
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF AI/GEN AI ON FILL FINISH MANUFACTURING MARKET
5.17 TRADE DATA ANALYSIS
5.17.1 GLASS AMPOULES
5.17.2 ARTICLES FOR CONVEYANCE OR PACKAGING OF PLASTIC GOODS, STOPPERS, LIDS, CAPS, AND OTHER CLOSURES
5.17.3 LABORATORY, HYGIENIC, OR PHARMACEUTICAL GLASSWARE, WHETHER OR NOT GRADUATED OR CALIBRATED
5.17.4 HYGIENIC OR PHARMACEUTICAL ARTICLES, INCLUDING TEATS OF VULCANIZED RUBBER (EXCL. HARD RUBBER), WITH OR WITHOUT FITTINGS OF HARD RUBBER
5.18 TRUMP TARIFF IMPACT ON FILL FINISH MANUFACTURING MARKET
5.18.1 KEY TARIFF RATES
5.18.2 PRICE IMPACT ANALYSIS
5.18.3 KEY IMPACT ON VARIOUS REGIONS
5.18.3.1 US
5.18.3.2 Europe
5.18.3.3 Asia Pacific
5.18.3.4 Rest of the World
5.18.4 END-USE INDUSTRY IMPACT
5.18.4.1 Contract manufacturing organizations
5.18.4.2 Pharmaceutical & biopharmaceutical companies
5.18.4.3 Other end users

6 FILL FINISH MANUFACTURING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 PREFILLABLE SYRINGES
6.2.1.1 Rising need for high-quality drug delivery systems to boost market
6.2.1.2 Prefillable syringes, by component
6.2.1.2.1 Prefillable syringe systems and components
6.2.1.3 Plunger stoppers
6.2.1.3.1 Rising prevalence of chronic diseases to positively impact pre-fillable syringes plunger stopper growth
6.2.1.4 Prefillable syringes, by material
6.2.1.4.1 Glass pre filled syringes
6.2.1.4.2 Polymer prefilled syringes
6.2.2 VIALS
6.2.2.1 Increased vaccination and treatment applications to drive growth
6.2.2.2 Vials, by material
6.2.2.2.1 Glass vials
6.2.2.2.2 Polymer vials
6.2.2.3 Vials, by format
6.2.2.3.1 Bulk vials
6.2.2.3.2 RTU vials
6.2.3 VIAL STOPPERS
6.2.3.1 Vial stoppers, by type
6.2.3.1.1 RTS/RFS vial stoppers
6.2.3.1.2 RTU vials stopper
6.2.4 CARTRIDGES
6.2.4.1 Rising cases of diabetes and autoimmune disorders to drive growth of cartridges
6.2.5 CELL THERAPY FILL FINISH BAGS
6.2.5.1 Specialized fill-finish bags enable safe and sterile cell therapy delivery
6.2.6 OTHER CONSUMABLES
6.3 INSTRUMENTS
6.3.1 INSTRUMENTS, BY SYSTEM TYPE
6.3.1.1 Rise in applications to drive market growth
6.3.1.2 Integrated systems
6.3.1.2.1 Higher product yield and automation to drive market growth
6.3.1.3 Standalone systems
6.3.1.3.1 Customization-a key factor driving growth
6.3.2 INSTRUMENTS, BY MACHINE TYPE
6.3.2.1 Increased technological advancements to drive growth of machines market
6.3.2.2 Automated machines
6.3.2.2.1 Technological advancements attributed to market growth
6.3.2.3 Semi-automated and manual machines
6.3.2.3.1 Popularity of benchtop equipment to drive market growth
6.3.3 FILL FINISH CDMO SERVICES MARKET

7 FILL FINISH MANUFACTURING MARKET, BY END USER
7.1 INTRODUCTION
7.2 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
7.2.1 GROWING PACE OF OUTSOURCING TO BENEFIT CMO SECTOR
7.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
7.3.1 INVESTMENTS IN NEW BIOLOGICS PRODUCTION FACILITIES TO DRIVE MARKET
7.4 OTHERS

8 FILL FINISH MANUFACTURING MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS
8.2.2 US
8.2.2.1 Rising number of pipeline products for fill finish manufacturing to drive market
8.2.3 CANADA
8.2.3.1 Competitive business environment to boost market
8.3 EUROPE
8.3.1 EUROPE: MACROECONOMIC ANALYSIS
8.3.2 GERMANY
8.3.2.1 Rising focus on clinical research and patent approvals to drive market
8.3.3 UK
8.3.3.1 Growth in biopharmaceutical industry to support market growth
8.3.4 FRANCE
8.3.4.1 Increasing focus on developing biologics to drive demand for fill-finish technologies
8.3.5 ITALY
8.3.5.1 Investments and advancements to drive market
8.3.6 SPAIN
8.3.6.1 Innovations in fill finish manufacturing market to drive growth
8.3.7 SWITZERLAND
8.3.7.1 Outsourcing trends and collaboration with contract manufacturing organizations to drive growth
8.3.8 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS
8.4.2 CHINA
8.4.2.1 Increased investments in biologics and biosimilar drug research to drive market
8.4.3 JAPAN
8.4.3.1 Rise in aging population to drive demand for medications
8.4.4 INDIA
8.4.4.1 Large domestic consumption and export of generic drugs to drive market
8.4.5 SOUTH KOREA
8.4.5.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market
8.4.6 REST OF ASIA PACIFIC
8.5 LATIN AMERICA
8.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS
8.5.2 BRAZIL
8.5.2.1 Free and universal healthcare services to boost market
8.5.3 MEXICO
8.5.3.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products
8.5.4 REST OF LATIN AMERICA
8.6 MIDDLE EAST
8.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS
8.6.2 GCC COUNTRIES
8.6.2.1 Saudi Arabia (KSA)
8.6.2.1.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
8.6.2.2 United Arab Emirates (UAE)
8.6.2.2.1 Increasing initiatives for domestic pharmaceutical production to drive market
8.6.2.3 Rest of GCC
8.6.3 REST OF MIDDLE EAST
8.7 AFRICA
8.7.1 GROWING COLLABORATIONS TO SUPPORT GROWTH

9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FILL FINISH MANUFACTURING MARKET, 2022-2024
9.3 REVENUE ANALYSIS, 2022-2024
9.4 MARKET SHARE ANALYSIS, 2024
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
9.5.5 COMPETITIVE BENCHMARKING OF TOP PLAYERS
9.5.6 COMPANY FOOTPRINT
9.5.6.1 Region footprint
9.5.6.2 Product footprint
9.5.6.3 End user footprint
9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
9.6.1 PROGRESSIVE COMPANIES
9.6.2 RESPONSIVE COMPANIES
9.6.3 DYNAMIC COMPANIES
9.6.4 STARTING BLOCKS
9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
9.7 VALUATION AND FINANCIAL METRICS OF FILL FINISH MANUFACTURING MARKET VENDORS
9.7.1 FINANCIAL METRICS
9.7.2 COMPANY VALUATION
9.8 BRAND/PRODUCT COMPARISON
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT APPROVALS
9.9.2 DEALS
9.9.3 EXPANSIONS

10 COMPANY PROFILES
10.1 KEY PLAYERS
10.1.1 SYNTEGON TECHNOLOGY GMBH
10.1.1.1 Business overview
10.1.1.2 Products/Services/Solutions offered
10.1.1.3 Recent developments
10.1.1.3.1 Product launches and approvals
10.1.1.3.2 Deals
10.1.1.3.3 Expansions
10.1.1.3.4 Other developments
10.1.1.4 MnM view
10.1.1.4.1 Key strengths
10.1.1.4.2 Strategic choices
10.1.1.4.3 Weaknesses & competitive threats
10.1.2 I.M.A. S.P.A.
10.1.2.1 Business overview
10.1.2.2 Products/Services/Solutions offered
10.1.2.3 Recent developments
10.1.2.3.1 Deals
10.1.2.4 MnM view
10.1.2.4.1 Key strengths/Right to win
10.1.2.4.2 Strategic choices
10.1.2.4.3 Weaknesses & competitive threats
10.1.3 BD & CO
10.1.3.1 Business overview
10.1.3.2 Products/Services/Solutions offered
10.1.3.3 Recent developments
10.1.3.3.1 Product launches and approvals
10.1.3.3.2 Deals
10.1.3.3.3 Expansions
10.1.3.4 MnM view
10.1.3.4.1 Key strengths/Right to win
10.1.3.4.2 Strategic choices
10.1.3.4.3 Weaknesses & competitive threats
10.1.4 WEST PHARMACEUTICAL SERVICES, INC.
10.1.4.1 Business overview
10.1.4.2 Products/Services/Solutions offered
10.1.4.3 Recent developments
10.1.4.3.1 Product launches and approvals
10.1.4.3.2 Deals
10.1.4.3.3 Expansions
10.1.4.4 MnM view
10.1.4.4.1 Key strengths/Right to win
10.1.4.4.2 Strategic choices
10.1.4.4.3 Weaknesses & competitive threats
10.1.5 GERRESHEIMER AG
10.1.5.1 Business overview
10.1.5.2 Products/Services/Solutions offered
10.1.5.3 Recent developments
10.1.5.3.1 Product launches and approvals
10.1.5.3.2 Deals
10.1.5.3.3 Expansions
10.1.5.4 MnM view
10.1.5.4.1 Key strengths/Right to win
10.1.5.4.2 Strategic choices
10.1.5.4.3 Weaknesses & competitive threats
10.1.6 APTARGROUP, INC.
10.1.6.1 Business overview
10.1.6.2 Products/Services/Solutions offered
10.1.6.3 Recent developments
10.1.6.3.1 Product launches and approvals
10.1.6.3.2 Deals
10.1.6.3.3 Expansions
10.1.7 DATWYLER HOLDING INC.
10.1.7.1 Business overview
10.1.7.2 Products/Services/Solutions offered
10.1.7.3 Recent developments
10.1.7.3.1 Product launches and approvals
10.1.7.3.2 Deals
10.1.7.3.3 Expansions
10.1.8 DANAHER CORPORATION
10.1.8.1 Business overview
10.1.8.2 Products/Services/Solutions offered
10.1.8.3 Recent developments
10.1.8.3.1 Deals
10.1.9 STEVANATO GROUP S.P.A.
10.1.9.1 Business overview
10.1.9.2 Products/Services/Solutions offered
10.1.9.3 Recent developments
10.1.9.3.1 Product launches and approvals
10.1.9.3.2 Deals
10.1.9.3.3 Expansions
10.1.10 OPTIMA
10.1.10.1 Business overview
10.1.10.2 Products/Services/Solutions offered
10.1.10.3 Recent developments
10.1.10.3.1 Deals
10.1.10.3.2 Expansions
10.1.11 BAUSCH+STROBEL
10.1.11.1 Business overview
10.1.11.2 Products/Services/Solutions offered
10.1.11.3 Recent developments
10.1.11.3.1 Product launches and approvals
10.1.12 GRONINGER & CO. GMBH
10.1.12.1 Business overview
10.1.12.2 Products/Services/Solutions offered
10.1.12.3 Recent developments
10.1.12.3.1 Expansions
10.1.13 SGD PHARMA
10.1.13.1 Business overview
10.1.13.2 Products/Services/Solutions offered
10.1.13.3 Recent developments
10.1.13.3.1 Product launches and approvals
10.1.13.3.2 Deals
10.1.13.3.3 Expansions
10.1.14 SCHOTT
10.1.14.1 Business overview
10.1.14.2 Products/Services/Solutions offered
10.1.14.3 Recent developments
10.1.14.3.1 Product launches and approvals
10.1.14.3.2 Deals
10.1.14.3.3 Expansions
10.1.14.3.4 Other developments
10.1.15 NIPRO CORPORATION
10.1.15.1 Business overview
10.1.15.2 Products/Services/Solutions offered
10.1.15.3 Recent developments
10.1.15.3.1 Product launches and approvals
10.1.15.3.2 Expansions
10.1.16 BAUSCH ADVANCED TECHNOLOGY GROUP
10.1.16.1 Business overview
10.1.16.2 Products/Services/Solutions offered
10.1.17 MAQUINARIA INDUSTRIAL DARA, SL
10.1.17.1 Business overview
10.1.17.2 Products/Services/Solutions offered
10.1.17.3 Recent developments
10.1.17.3.1 Product launches and approvals
10.1.17.3.2 Deals
10.2 OTHER PLAYERS
10.2.1 STERILINE S.R.L.
10.2.2 AUTOMATED SYSTEMS OF TACOMA, LLC
10.2.3 SIO2 MATERIALS SCIENCE
10.2.4 WEILER ENGINEERING, INC.
10.2.5 FEDEGARI AUTOCLAVI S.P.A.
10.2.6 SHANDONG PHARMACEUTICAL GLASS
10.2.7 MITSUBISHI GAS CHEMICAL
10.2.8 TERUMO CORPORATION
10.2.9 SKAN AG
10.2.10 ATS LIFE SCIENCE SYSTEMSn
10.2.11 CORNING INC.
10.2.12 CREDENCE MEDSYSTEMS
10.2.13 3P INNOVATION LTD.
10.2.14 COLANAR AG.

11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS